Subacute sclerosing panencephalitis

被引:210
作者
Garg, RK [1 ]
机构
[1] King Georges Med Coll, Dept Neurol, Lucknow 226003, Uttar Pradesh, India
关键词
D O I
10.1136/pmj.78.916.63
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Subacute sclerosing panencephalitis (SSPE) is a progressive neurological disorder of childhood and early adolescence. It is caused by persistent clefective measles virus. Brain biopsies or postmortem histopathological examination show evidence of astrogliosis, neuronal loss, degeneration of dendrites, demyelination, neurofibrillary tangles, and infiltration of inflammatory cells. Patients usually have behavioral changes, myoclonus, dementia, visual disturbances, and pyramidal and extrapyramidal signs. The disease has a gradual progressive course leading to death within 1-3 years. The diagnosis is based upon characteristic clinical manifestations, the presence of characteristic periodic EEG discharges, and demonstration of raised antibody titre against measles in the plasma and cerebrospinal fluid. Treatment for SSPE is still undetermined. A combination of oral isoprinosine (Inosiplex) and intraventricular interferon alfa appears to be the best effective treatment. Patients responding to treatment need to receive it life long. Effective immunisation against measles is the only solution presently available to the problem of this dreaded disease.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 88 条
[1]  
AABY P, 1984, REV INFECT DIS, V6, P239
[2]   DIFFERENT VIRUS-ANTIBODIES IN SERUM AND CEREBROSPINAL-FLUID OF PATIENTS SUFFERING FROM SUB-ACUTE SCLEROSING PANENCEPHALITIS [J].
ABDELNOOR, AM ;
DHIBJALBUT, SS ;
HADDAD, FS .
JOURNAL OF NEUROIMMUNOLOGY, 1982, 2 (01) :27-34
[3]  
Alexander M, 1999, NEUROL INDIA, V47, P304
[4]   Significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination [J].
Allen, IV ;
McQuaid, S ;
McMahon, J ;
Kirk, J ;
McConnell, R .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (04) :471-480
[5]   Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon [J].
Anlar, B ;
Yalaz, K ;
Oktem, F ;
Kose, G .
NEUROLOGY, 1997, 48 (02) :526-528
[6]   Apoptosis in brain biopsies of subacute sclerosing panencephalitis patients [J].
Anlar, B ;
Söylemezoglu, F ;
Elibol, B ;
Dalkara, T ;
Aysun, S ;
Köse, G ;
Belen, D ;
Yalaz, K .
NEUROPEDIATRICS, 1999, 30 (05) :239-242
[7]   β-interferon plus inosiplex in the treatment of subacute sclerosing panencephalitis [J].
Anlar, B ;
Yalaz, K ;
Köse, G ;
Saygi, S .
JOURNAL OF CHILD NEUROLOGY, 1998, 13 (11) :557-559
[8]   CIMETIDINE AS AN IMMUNOMODULATOR IN SUBACUTE SCLEROSING PANENCEPHALITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
ANLAR, B ;
GUCUYENER, K ;
IMIR, T ;
YALAZ, K ;
RENDA, Y .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (07) :578-581
[9]   MRI findings in subacute sclerosing panencephalitis [J].
Anlar, B ;
Saatci, I ;
Kose, G ;
Yalaz, K .
NEUROLOGY, 1996, 47 (05) :1278-1283
[10]   CLONAL EXPANSION OF HYPERMUTATED MEASLES-VIRUS IN A SSPE BRAIN [J].
BACZKO, K ;
LAMPE, J ;
LIEBERT, UG ;
BRINCKMANN, U ;
TERMEULEN, V ;
PARDOWITZ, I ;
BUDKA, H ;
COSBY, SL ;
ISSERTE, S ;
RIMA, BK .
VIROLOGY, 1993, 197 (01) :188-195